Shaurix Pharmaceuticals Private Limited
About Shaurix Pharmaceuticals Private Limited
Data last updated:
Shaurix Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It was incorporated on 23 January 2026, which makes it a newly registered company.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U46497DL2026PTC462316.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nikhil Bhargava and Shilpa Bhargava.
Its last annual general meeting (AGM) was held on 30 May 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at A – 306 Bhrigu Appartments, Plot No 4 Sector 9 Dwarka, New Delhi, Delhi, India – 110077.
As per the financials filed for FY 2026, the company reported a revenue of ₹2.68 Lakh. For the same year it recorded a net profit of ₹8,956 (net margin 3.3%) and EBITDA of ₹13,148 (EBITDA margin 4.9%).
Company details
Contact details
Shaurix Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressA – 306 Bhrigu Appartments, Plot No 4 Sector 9 Dwarka, New Delhi, Delhi, India – 110077
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Shaurix Pharmaceuticals Private Limited
FY 2026 filings availableShaurix Pharmaceuticals Private Limited reported revenue of ₹2.68 Lakh for FY 2026.
Financial Statement Summary
| Metrics | FY 2025-26 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | ₹2.68 Lakh |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹13,148 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹8,956 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2025-26 |
|---|---|
| Profitability | |
| EBITDA Margin | 4.9% |
| Net Profit Margin | 3.3% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Shaurix Pharmaceuticals Private Limited, buy the company report.
Board of directors of Shaurix Pharmaceuticals Private Limited
Shaurix Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikhil Bhargava | Director | 23 Jan 2026 | 0 Years 9 Months | Current |
| Shilpa Bhargava | Director | 23 Jan 2026 | 0 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Shaurix Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shaurix Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Shaurix Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Shaurix Pharmaceuticals Private Limited has 2 board changes on record: 2 appointments. The latest: Nikhil Bhargava was appointed as Director on 23 Jan 2026.
Frequently asked questions
Shaurix Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. It was incorporated on 23 January 2026 and is registered under CIN U46497DL2026PTC462316.
Shaurix Pharmaceuticals has 2 current directors:
- Nikhil Bhargava - Director
- Shilpa Bhargava - Director
The latest financial statements of Shaurix Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 May 2026.
The CIN (Corporate Identification Number) of Shaurix Pharmaceuticals is U46497DL2026PTC462316. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shaurix Pharmaceuticals was incorporated on 23 January 2026. It is registered with the Registrar of Companies, Delhi.
Nikhil Bhargava was appointed as Director on 23 Jan 2026. Shilpa Bhargava was appointed as Director on 23 Jan 2026.
The registered office of Shaurix Pharmaceuticals is at A – 306 Bhrigu Appartments, Plot No 4 Sector 9 Dwarka, New Delhi, Delhi, India – 110077.
Shaurix Pharmaceuticals can be reached at its registered office: A – 306 Bhrigu Appartments, Plot No 4 Sector 9 Dwarka, New Delhi, Delhi, India – 110077.
Shaurix Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
